Gordon Okawara

2.5k total citations · 1 hit paper
29 papers, 1.7k citations indexed

About

Gordon Okawara is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Gordon Okawara has authored 29 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 7 papers in Surgery. Recurrent topics in Gordon Okawara's work include Lung Cancer Diagnosis and Treatment (13 papers), Lung Cancer Treatments and Mutations (9 papers) and Gastric Cancer Management and Outcomes (6 papers). Gordon Okawara is often cited by papers focused on Lung Cancer Diagnosis and Treatment (13 papers), Lung Cancer Treatments and Mutations (9 papers) and Gastric Cancer Management and Outcomes (6 papers). Gordon Okawara collaborates with scholars based in Canada, United States and South Africa. Gordon Okawara's co-authors include Thomas M. Pisansky, David P. Kelsen, James A. Martenson, Robert J. Ginsberg, Bruce D. Minsky, Seth A. Rosenthal, Thomas F. Pajak, Ritsuko Komaki, Yee Ung and William K. Evans and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Gordon Okawara

26 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III Trial of Combined-Modality Therapy for Esophageal Cancer: High-Dose Versus Standard-Dose Radiation Therapy

2002 799 citations Bruce D. Minsky, Thomas F. Pajak et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Gordon Okawara

Since Specialization

Citations

This map shows the geographic impact of Gordon Okawara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon Okawara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon Okawara more than expected).

Fields of papers citing papers by Gordon Okawara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon Okawara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon Okawara. The network helps show where Gordon Okawara may publish in the future.

Co-authorship network of co-authors of Gordon Okawara

This figure shows the co-authorship network connecting the top 25 collaborators of Gordon Okawara. A scholar is included among the top collaborators of Gordon Okawara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gordon Okawara. Gordon Okawara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Growth differentiation factor 15 (GDF15) predicts relapse free and overall survival in unresected locally advanced non-small cell lung cancer treated with chemoradiotherapy 2024 ·Radiation Oncology ·(unknown), Gregory R. Pond, (unknown), (unknown), Elham Ahmadi, (unknown), (unknown), Anand Swaminath, Gordon Okawara, Peter Ellis, Bassam Abdulkarim, (unknown), Andrew Robinson, Wilson Roa, Mario J. Valdés, Peter A. Kavsak, Marcin Wierzbicki, James Wright, Gregory R. Steinberg, Theodoros Tsakiridis	3
2	Toxicity in patients receiving radiotherapy for ultracentral stage I non-small cell lung cancer: A secondary analysis of the LUSTRE randomized trial 2024 ·Radiotherapy and Oncology ·(unknown), Marcin Wierzbicki, Sameer Parpia, Vijayananda Kundapur, Alexis Bujold, Édith Filion, Harold Lau, Sergio Faria, (unknown), (unknown), Gordon Okawara, Khalid Hirmiz, (unknown), Alexander V. Louie, James R. Wright, Timothy J. Whelan, Anand Swaminath	0
3	The impact of staging FDG-PET/CT on treatment for stage III NSCLC - an analysis of population-based data from Ontario, Canada 2023 ·Frontiers in Oncology ·(unknown), Gregory R. Pond, James R. Wright, Theodoros Tsakiridis, Gordon Okawara, Anand Swaminath	0
4	LUSTRE: A Phase III Randomized Trial of Stereotactic Body Radiotherapy (SBRT) vs. Conventionally Hypofractionated Radiotherapy (CRT) for Medically Inoperable Stage I Non-Small Cell Lung Cancer (NSCLC) 2022 ·International Journal of Radiation OncologyBiologyPhysics ·Anand Swaminath, Sameer Parpia, Marcin Wierzbicki, (unknown), Sergio Faria, Gordon Okawara, Theodoros Tsakiridis, (unknown), Alexis Bujold, Khalid Hirmiz, (unknown), (unknown), (unknown), Édith Filion, Harold Lau, (unknown), (unknown), (unknown), James R. Wright, Timothy J. Whelan	4
5	Metformin in Combination With Chemoradiotherapy in Locally Advanced Non–Small Cell Lung Cancer 2021 ·JAMA Oncology ·Theodoros Tsakiridis, Gregory R. Pond, James R. Wright, Peter Ellis, (unknown), Bassam Abdulkarim, Wilson Roa, Andrew Robinson, Anand Swaminath, Gordon Okawara, Marcin Wierzbicki, Mario J. Valdés, Mark N. Levine	76
6	Genome-wide host methylation profiling of anal and cervical carcinoma 2021 ·PLoS ONE ·Erin M. Siegel, Abidemi Ajidahun, Anders Berglund, (unknown), Steven A. Eschrich, Ryan M. Putney, Anthony M. Magliocco, (unknown), Kathryn Winter, Jeff Simko, Jaffer A. Ajani, Chandan Guha, Gordon Okawara, Ibrahim Abdalla, (unknown), Joseph F. Pizzolato, Christopher H. Crane, Kevin D. Brown, David Shibata	11
7	The Genomic Landscape of Anal Cancer and Its Relationship to Clinical Outcomes: An Exploratory Analysis of NRG Oncology/RTOG 98-11 2019 ·International Journal of Radiation OncologyBiologyPhysics ·David J. Konieczkowski, Bhupendra Rawal, Brendan Reardon, (unknown), Abidemi Ajidahun, Harvey J. Mamon, David Shibata, Jaffer A. Ajani, Al B. Benson, Charles R. Thomas, Michael G. Haddock, Gordon Okawara, Joseph F. Pizzolato, Paul Catalano, Jennifer Moughan, Adam P. Dicker, Eliezer M. Van Allen, Kent W. Mouw	0
8	MEDiastinal Irradiation and CArdio-Toxic Effects (MEDICATE): Exploring the Relationship between Cardiac Irradiation and High Sensitivity Troponins 2019 ·Clinical Oncology ·E. Donovan, Sukhbinder Dhesy‐Thind, Anand Swaminath, Darryl P. Leong, Gregory R. Pond, S. Voruganti, Jonathan Sussman, James R. Wright, Gordon Okawara, Peter A. Kavsak, Hisham Dokainish, Graham Fraser, Stephen M. Sagar	4
9	A Novel Neoadjuvant Therapy for Operable Locally Invasive Non–Small-Cell Lung Cancer. Phase I Study of Neoadjuvant Stereotactic Body Radiotherapy. LINNEARRE I (NCT02433574) 2017 ·Clinical Lung Cancer ·(unknown), (unknown), Gregory R. Pond, Waël C. Hanna, Jean-Claude Cutz, James R. Wright, Anand Swaminath, Yaron Shargall, (unknown), Marcin Wierzbicki, Gordon Okawara, (unknown), Christian Finley, Rosalyn A. Juergens, Theodoros Tsakiridis	7
10	Significance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of NRG Oncology RTOG 9811 2016 ·International Journal of Radiation OncologyBiologyPhysics ·Corinne Doll, Jennifer Moughan, Alexander C. Klimowicz, Clement Ho, Elizabeth Kornaga, Susan P. Lees‐Miller, Jaffer A. Ajani, Christopher H. Crane, Lisa A. Kachnic, Gordon Okawara, Lawrence Berk, Kevin S. Roof, (unknown), (unknown), Robert J. Ellis, Paul W. Sperduto, Gerald W. Marsa, Chandan Guha, Anthony M. Magliocco	9
11	Early Occurrence of Angiosarcoma in a Woman With a BRCA2 Gene Variation of Unknown Significance Treated With Breast-Conserving Therapy for Bilateral Ductal Carcinoma: A Case Report 2015 ·Clinical Breast Cancer ·Elena Parvez, Snežana Popović, (unknown), Gordon Okawara, Nicole Hodgson	9
12	A Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation for Patients With Non–Small-Cell Lung Cancer 2015 ·Clinical Lung Cancer ·Anand Swaminath, James R. Wright, Theodoros Tsakiridis, Yee Ung, Gregory R. Pond, Ranjan Sur, Thomas Corbett, Gordon Okawara, Mark N. Levine	7
13	The Significance of p16 and p53 Expression on Clinical Outcome in Patients with Anal Cancer Treated with Chemoradiation Therapy: An Analysis of RTOG 98-11 2014 ·International Journal of Radiation OncologyBiologyPhysics ·Corinne Doll, Kathryn Winter, Jaffer A. Ajani, Alexander C. Klimowicz, Christopher H. Crane, Lisa A. Kachnic, Gordon Okawara, Himu Lukka, Lawrence Berk, Kevin S. Roof, (unknown), (unknown), Chandan Guha, Anthony M. Magliocco	1
14	Predicting 2-Year Survival for Radiation Regimens in Advanced Non-small Cell Lung Cancer 2013 ·Clinical Oncology ·Waseem Sharieff, Gordon Okawara, Theodoros Tsakiridis, James R. Wright	8
15	Randomized, Double-Blind, Placebo-Controlled, Phase III Chemoprevention Trial of Selenium Supplementation in Patients With Resected Stage I Non–Small-Cell Lung Cancer: ECOG 5597 2013 ·Journal of Clinical Oncology ·Daniel D. Karp, Sandra J. Lee, Steven M. Keller, Gail S. Wright, Seena C. Aisner, Steven A. Belinsky, David H. Johnson, Michael R. Johnston, Gary E. Goodman, Gerald H. Clamon, Gordon Okawara, Randolph S. Marks, Éric Fréchette, Worta McCaskill‐Stevens, Scott M. Lippman, John Ruckdeschel, Fadlo R. Khuri	82
16	A phase III, intergroup, randomized, double-blind, chemoprevention trial of selenium (Se) supplementation in resected stage I non-small cell lung cancer (NSCLC). 2010 ·Journal of Clinical Oncology ·Daniel D. Karp, Seung‐Jae Lee, (unknown), David H. Johnson, Michael R. Johnston, (unknown), Gerald H. Clamon, Gordon Okawara, Randolph S. Marks, John C. Ruckdeschel	9
17	Association of Phosphorylated Epidermal Growth Factor Receptor with Survival in Patients with Locally Advanced Non-small Cell Lung Cancer Treated with Radiotherapy 2008 ·Journal of Thoracic Oncology ·Theodoros Tsakiridis, Jean‐Claude Cutz, Gurmit Singh, Hal W. Hirte, Gordon Okawara, Tom Corbett, Ranjan Sur, Wenjie Cai, Timothy J. Whelan, James R. Wright	14
18	Postoperative radiotherapy in stage II or IIIA completely resected non-small cell lung cancer: a systematic review and practice guideline 2003 ·Lung Cancer ·Gordon Okawara, Yee Ung, (unknown), Jean A. Mackay, William K. Evans	30
19	INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III Trial of Combined-Modality Therapy for Esophageal Cancer: High-Dose Versus Standard-Dose Radiation Therapy breakdown → 2002 ·Journal of Clinical Oncology ·Bruce D. Minsky, Thomas F. Pajak, Robert J. Ginsberg, Thomas M. Pisansky, James A. Martenson, Ritsuko Komaki, Gordon Okawara, Seth A. Rosenthal, David P. Kelsen	799
20	Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer 2001 ·JNCI Journal of the National Cancer Institute ·Scott M. Lippman, J. Jack Lee, Daniel D. Karp, Everett E. Vokes, Steven E. Benner, Gary E. Goodman, Fadlo R. Khuri, Randolph S. Marks, R Winn, (unknown), S. L. Graziano, David R. Gandara, Gordon Okawara, (unknown), Betsy Williams, Carlos A. Pérez, (unknown), R. Lotan, Jack A. Roth, W. K. Hong	213

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact